首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1620439

照護端傳染病檢測市場機會、成長動力、產業趨勢分析與預測 2024 - 2032 年

Point of Care Infectious Disease Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月22日 | 出版商:

Global Market Insights Inc. | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球照護端傳染病檢測市場價值為 32 億美元，預計 2024 年至 2032 年將以 6.9% 的年複合成長率(CAGR) 成長。現場進行測試，可快速提供結果，有助於立即做出臨床決策，而無需集中實驗室。推動POC傳染病檢測市場擴大的主要因素之一是全球傳染病負擔不斷上升。新病原體的出現、先前受到控制的疾病的死灰復燃以及抗菌素抗藥性日益嚴重的威脅，都凸顯了對快速、準確的診斷解決方案的迫切需求。流感、愛滋病毒、肝炎和結核病等疾病持續對全球健康構成重大挑戰，進一步增加了對 POC 檢測的需求。

技術進步在加速 POC 傳染病檢測的採用方面發揮著至關重要的作用。設備小型化、數位平台整合以及快速分子測試的發展等方面的創新顯著提高了這些診斷的便攜性、準確性和速度。具有即時數據共享功能的自動化設備正在改變現場檢測的效率，使其在傳統實驗室訪問可能受到限制的偏遠或資源有限的環境中非常有價值。此外，POC 測試提供的現場結果的便利性越來越受到醫療保健提供者和患者的青睞，因為它可以帶來更有效的患者管理和更好的健康結果。

這對於管理傳染病尤其重要，因為及時診斷可以顯著影響治療決策並有助於控制感染的傳播。隨著全球醫療保健產業更加重視早期檢測和快速治療，POC傳染病檢測市場必將持續成長。這種成長得到了對改善服務欠缺地區的醫療保健服務的日益關注，以及旨在提高測試準確性和降低成本的持續投資研發的進一步支持。總體而言，不斷成長的醫療保健需求、技術創新以及對快速、可操作的診斷資訊的需求相結合，使即時傳染病檢測市場在未來幾年持續擴張。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	32億美元
預測值	59 億美元
複合年成長率	6.9%

產業生態系統分析
產業影響力
- 成長動力
  - 傳染病病率上升
  - 即時檢測設備的技術進步
  - 人們對現場檢測的意識不斷增強
- 產業陷阱與挑戰
  - POC測試開發成本高
  - 對準確性和可靠性的擔憂
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
未來市場趨勢
差距分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
試劑盒和試劑
儀器儀表

第 6 章：市場估計與預測：按技術分類，2021 - 2032 年

主要趨勢
分子診斷
側流免疫分析
凝集試驗
流通測試/免疫濃度測定
其他技術

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
熱帶疾病
肝臟疾病
呼吸系統疾病
醫院相關感染
性健康障礙
其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
診斷中心
研究和學術機構
家庭護理設置
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第 10 章：公司簡介

Abbott Laboratories
Becton, Dickinson and Company
Biomerieux
Bio-Rad Laboratories
Cardinal Health
Chembio Diagnostics
Danaher Corporation
F. Hoffmann-La Roche
OJ-Bio
QuidelOrtho Corporation
Siemens Healthineers
Trinity Biotech
Trivitron Healthcare

簡介目錄

Product Code: 11938

The Global Point Of Care Infectious Disease Testing Market was valued at USD 3.2 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2032. Point-of-care infectious disease testing refers to diagnostic tests performed near or at the site of patient care, providing rapid results that facilitate immediate clinical decision-making, without the need for centralized laboratories. One of the main factors driving the expansion of the POC infectious disease testing market is the rising global burden of infectious diseases. The emergence of new pathogens, the resurgence of diseases that were previously under control, and the increasing threat of antimicrobial resistance underscore the critical need for rapid and accurate diagnostic solutions. Diseases such as influenza, HIV, hepatitis, and tuberculosis continue to pose significant health challenges worldwide, further boosting the demand for POC testing.

Technological advancements are playing a crucial role in accelerating the adoption of POC infectious disease testing. Innovations in device miniaturization, the integration of digital platforms, and the development of rapid molecular testing have significantly improved the portability, accuracy, and speed of these diagnostics. Automated devices with real-time data-sharing capabilities are transforming the efficiency of point-of-care testing, making them highly valuable in remote or resource-constrained settings where access to traditional laboratories may be limited. Furthermore, the convenience of on-the-spot results provided by POC tests is increasingly favored by healthcare providers and patients alike, as it leads to more efficient patient management and better health outcomes.

This is particularly important in managing infectious diseases where timely diagnosis can significantly impact treatment decisions and help control the spread of infections. With the global healthcare industry placing a stronger emphasis on early detection and rapid treatment, the POC infectious disease testing market is set to experience sustained growth. This growth is further supported by an increasing focus on improving healthcare access in underserved regions, as well as ongoing investments in research and development aimed at enhancing test accuracy and reducing costs. Overall, the combination of rising healthcare needs, technological innovation, and demand for quick, actionable diagnostic information positions the point-of-care infectious disease testing market for continued expansion in the coming years.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$3.2 Billion
Forecast Value	$5.9 Billion
CAGR	6.9%

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of infectious diseases
  - 3.2.1.2 Technological advancements in point of care testing devices
  - 3.2.1.3 Growing awareness among people for point of care testing
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High development cost of POC tests
  - 3.2.2.2 Concerns about accuracy and reliability
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Kits and reagents
5.3 Instruments

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Molecular diagnostics
6.3 Lateral flow immunoassay
6.4 Agglutination test
6.5 Flow-through Test/Immunoconcentration assay
6.6 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Tropical diseases
7.3 Liver diseases
7.4 Respiratory diseases
7.5 Hospital associated infections
7.6 Sexual health disorders
7.7 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic centers
8.4 Research and academic institutes
8.5 Homecare settings
8.6 Others end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE